Pam S. Dellea

558 total citations
11 papers, 438 citations indexed

About

Pam S. Dellea is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Pam S. Dellea has authored 11 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Pam S. Dellea's work include Synthesis of β-Lactam Compounds (5 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Healthcare Policy and Management (1 paper). Pam S. Dellea is often cited by papers focused on Synthesis of β-Lactam Compounds (5 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Healthcare Policy and Management (1 paper). Pam S. Dellea collaborates with scholars based in United States, Germany and Canada. Pam S. Dellea's co-authors include Benjamin T. Allaire, Eric Finkelstein, Sachin Kamal‐Bahl, Justin G. Trogdon, Derek S. Brown, Bonnie M. Ashe, Alan L. Maycock, D. Fletcher, Gilbert O. Chandler and James B. Doherty and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Journal of Cellular Biochemistry.

In The Last Decade

Pam S. Dellea

11 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pam S. Dellea United States 8 124 85 84 74 68 11 438
Elizabeth R. Berger United States 12 261 2.1× 31 0.4× 34 0.4× 29 0.4× 59 0.9× 29 584
Bernice Tsoi Canada 11 236 1.9× 19 0.2× 29 0.3× 117 1.6× 77 1.1× 29 499
Randall E. Harris United States 12 78 0.6× 29 0.3× 67 0.8× 19 0.3× 92 1.4× 19 624
S Freeman United States 13 78 0.6× 50 0.6× 65 0.8× 13 0.2× 23 0.3× 25 489
Paige E. Farris United States 14 177 1.4× 56 0.7× 72 0.9× 77 1.0× 214 3.1× 33 756
Shmuel Klang Israel 11 34 0.3× 46 0.5× 64 0.8× 39 0.5× 108 1.6× 12 546
Jacqueline L. Olin United States 13 48 0.4× 20 0.2× 49 0.6× 13 0.2× 55 0.8× 36 468
Thomas Brewster United States 9 153 1.2× 18 0.2× 55 0.7× 27 0.4× 33 0.5× 10 404
Claire Jenkinson United Kingdom 17 119 1.0× 15 0.2× 64 0.8× 229 3.1× 102 1.5× 17 906
Lalita Subramanian United States 17 49 0.4× 14 0.2× 110 1.3× 82 1.1× 33 0.5× 27 840

Countries citing papers authored by Pam S. Dellea

Since Specialization
Citations

This map shows the geographic impact of Pam S. Dellea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pam S. Dellea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pam S. Dellea more than expected).

Fields of papers citing papers by Pam S. Dellea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pam S. Dellea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pam S. Dellea. The network helps show where Pam S. Dellea may publish in the future.

Co-authorship network of co-authors of Pam S. Dellea

This figure shows the co-authorship network connecting the top 25 collaborators of Pam S. Dellea. A scholar is included among the top collaborators of Pam S. Dellea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pam S. Dellea. Pam S. Dellea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Gitt, Anselm K., Heinz Drexel, J. Feely, et al.. (2011). Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada. European Journal of Preventive Cardiology. 19(2). 221–230. 124 indexed citations
2.
Finkelstein, Eric, Justin G. Trogdon, Derek S. Brown, et al.. (2008). The Lifetime Medical Cost Burden of Overweight and Obesity: Implications for Obesity Prevention. Obesity. 16(8). 1843–1848. 123 indexed citations
3.
Price, David, Michel Rouleau, Piyush M. Patel, et al.. (2001). Use of Montelukast in tapering inhaled corticosteroid therapy: an open-label, 48-week trial. Current Therapeutic Research. 62(11). 743–755. 10 indexed citations
4.
Shah, S. K., D. Fletcher, Bonnie M. Ashe, et al.. (1995). Orally Active .beta.-Lactam Inhibitors of Human Leukocyte Elastase. 3. Stereospecific Synthesis and Structure-Activity Relationships for 3,3-Dialkylazetidin-2-ones. Journal of Medicinal Chemistry. 38(13). 2449–2462. 74 indexed citations
5.
6.
Thompson, Kevan R., Paul E. Finke, Shrenik K. Shah, et al.. (1993). Inhibition of human leukocyte elastase. 7. Inhibition by 6-substituted penicillin amides.. Bioorganic & Medicinal Chemistry Letters. 3(11). 2289–2294. 7 indexed citations
7.
Shah, Shrenik K., Conrad P. Dorn, Paul E. Finke, et al.. (1993). ChemInform Abstract: Orally Active β‐Lactam Inhibitors of Human Leukocyte Elastase‐1. Activity of 3,3‐Diethyl‐2‐azetidinones.. ChemInform. 24(20). 1 indexed citations
8.
Opas, Evan E., Pam S. Dellea, D. Fletcher, Philip R. Davies, & John L. Humes. (1991). The in Vitro and in Vivo Recovery of PMN Elastase:Beta‐Lactam Inhibitor Complexes by Cation Exchange Chromatography. Annals of the New York Academy of Sciences. 624(1). 348–349. 2 indexed citations
9.
Hagmann, William K., Shrenik K. Shah, Conrad P. Dorn, et al.. (1991). Prevention of human leukocyte elastase-mediated lung damage by 3-alkyl-4-azetidinones. Bioorganic & Medicinal Chemistry Letters. 1(10). 545–550. 25 indexed citations
10.
11.
Bonney, Robert J., Bonnie M. Ashe, Alan L. Maycock, et al.. (1989). Pharmacological profile of the substituted beta‐lactam L‐659,286: A member of a new class of human PMN elastase inhibitors. Journal of Cellular Biochemistry. 39(1). 47–53. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth R. Berger Breakdown of academic impact, for papers by Bernice Tsoi Breakdown of academic impact, for papers by Randall E. Harris Breakdown of academic impact, for papers by S Freeman Breakdown of academic impact, for papers by Paige E. Farris Breakdown of academic impact, for papers by Shmuel Klang Breakdown of academic impact, for papers by Jacqueline L. Olin Breakdown of academic impact, for papers by Thomas Brewster Breakdown of academic impact, for papers by Claire Jenkinson Breakdown of academic impact, for papers by Lalita Subramanian
Rankless by CCL
2026